Detalles de la búsqueda
1.
Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.
Int J Cancer
; 147(3): 702-708, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31675431
2.
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.
Int J Cancer
; 145(12): 3244-3256, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30873591
3.
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
JAMA
; 319(9): 883-895, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29509864
4.
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee.
Br J Cancer
; 115(1): 90-4, 2016 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27253172
5.
Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.
Int J Cancer
; 125(6): 1414-23, 2009 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19444909
6.
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
Ann Intern Med
; 149(7): 461-71, W83-8, 2008 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-18838726
7.
Time intervals from first symptom to diagnosis for head and neck cancers: An analysis of linked patient reports and medical records from the UK.
Cancer Epidemiol
; 59: 37-45, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30669114
8.
Patient non-attendance at urgent referral appointments for suspected cancer and its links to cancer diagnosis and one year mortality: A cohort study of patients referred on the Two Week Wait pathway.
Cancer Epidemiol
; 63: 101588, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520940
9.
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
BMJ Open
; 7(10): e017729, 2017 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29084797
10.
Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
PLoS One
; 12(12): e0187741, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281666
11.
Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Leuk Lymphoma
; 56(9): 2660-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651425
12.
Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Cancer Epidemiol Biomarkers Prev
; 13(1): 163-5, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14744750
13.
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
J Clin Epidemiol
; 56(7): 605-9, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12921927
14.
Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
BJU Int
; 98(4): 777-82, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16978272
15.
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.
Int J Cancer
; 108(6): 887-92, 2004 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14712493
16.
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Urology
; 64(2): 317-22, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15302487
Resultados
1 -
16
de 16
1
Próxima >
>>